| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 14 insiders with recent SEC Form 4 filings, including 4 buys and 10 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.39M | - | |
| Dir | 238.9K | $12.52M | - | |
| Other | 94.3K | $4.94M | - | |
| Other | 38.5K | $2.02M | - | |
| Dir | 22.0K | $1.15M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | Prasad Raju53 | Chief Financial Officer | Sell | 10,000 | $55.95 | $559,548.75 | -26.5% | -19.0% | - | |
| Oct 17, 2025 | Kulkarni Samarth69 | Chief Executive Officer | Sale+OE | 50,895 | $67.91 | $3,456,279.45 | -16.7% | -21.6% | - | |
| Oct 14, 2025 | Kulkarni Samarth69 | Chief Executive Officer | Sale+OE | 4,242 | $66.60 | $282,517.20 | -2.0% | -20.3% | - | |
| Oct 14, 2025 | Kasinger James R.64 | General Counsel And Secretary | Sale+OE | 1,076 | $66.60 | $71,661.60 | -1.3% | -20.3% | - | |
| Aug 18, 2025 | Kulkarni Samarth69 | Chief Executive Officer | Sale+OE | 13,081 | $58.15 | $760,660.15 | -5.9% | -3.9% | - | |
| Aug 6, 2025 | Treco Douglas A | Director | Buy | 20,000 | $57.03 | $1,140,600.00 | +1,000% | +0.1% | - | |
| Jul 16, 2025 | George Simeon | Director | Buy | 989,812 | $52.03 | $51,499,918.36 | +94.4% | +25.8% | - | |
| May 29, 2025 | Patel Naimish | Chief Medical Officer | Sale+OE | 3,932 | $35.94 | $141,316.08 | -39.3% | +45.5% | - | |
| Mar 21, 2025 | Bruno Julianne48 | Chief Operating Officer | Sale+OE | 1,714 | $41.23 | $70,668.22 | -14.0% | +7.4% | +12.2% | |
| Mar 21, 2025 | Prasad Raju53 | Chief Financial Officer | Sale+OE | 2,197 | $41.23 | $90,582.31 | -11.6% | +7.4% | +12.2% |